These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1122454)

  • 21. Use of methylphenidate for attention deficit hyperactivity disorder.
    Brostë SM
    CMAJ; 1990 Nov; 143(10):995, 998. PubMed ID: 2073256
    [No Abstract]   [Full Text] [Related]  

  • 22. [Methylphenidate. A possibility for rare hyperactive children].
    Rev Infirm; 2004 Sep; (103):39-40. PubMed ID: 15517803
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hyperkinetic syndrome and dyslexia. Medical help for the hyperactive child].
    Stiefelhagen P
    MMW Fortschr Med; 2002 May; 144(21):4-8. PubMed ID: 12134423
    [No Abstract]   [Full Text] [Related]  

  • 24. [Methylphenidate (Ritalin) treatment in attention deficit hyperactivity disorder].
    Shalev R; Gross-Tsur V
    Harefuah; 1997 May; 132(9):672-5. PubMed ID: 9225587
    [No Abstract]   [Full Text] [Related]  

  • 25. Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children.
    Rapport MD; DuPaul GJ; Kelly KL
    Psychopharmacol Bull; 1989; 25(2):285-90. PubMed ID: 2602521
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative effects of methylphenidate on attention-deficit hyperactivity disorder with and without aggressive/noncompliant features.
    Klorman R; Brumaghim JT; Salzman LF; Strauss J; Borgstedt AD; McBride MC; Loeb S
    Psychopharmacol Bull; 1989; 25(1):109-13. PubMed ID: 2772109
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of methylphenidate for attention deficit hyperactivity disorder. Mental Health Committee, Canadian Paediatric Society.
    CMAJ; 1990 Apr; 142(8):817-8. PubMed ID: 2322913
    [No Abstract]   [Full Text] [Related]  

  • 28. Family practice grand rounds. Hyperactivity: a symptom, not a disease entity.
    Authier J; Donaldson J; Prica G; Alperin E; Ensz G
    J Fam Pract; 1977 May; 4(5):965-70. PubMed ID: 405452
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mechanism for the efficacy of methylphenidate on attention deficit/hyperactivity disorder and related clinical evidence].
    Okada T
    Seishin Shinkeigaku Zasshi; 2008; 110(10):932-40. PubMed ID: 19278069
    [No Abstract]   [Full Text] [Related]  

  • 30. [Medical treatments of hyperactive child: about the new pharmaceutical forms of methylphenidate marketed in France].
    Le Heuzey MF; Vergnaud S; Mouren MC
    Arch Pediatr; 2006 Jan; 13(1):100-3. PubMed ID: 16239100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder.
    Liu C; Robin AL; Brenner S; Eastman J
    Pediatrics; 1991 Sep; 88(3):560-5. PubMed ID: 1881737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The minimal brain dysfunction syndrome].
    Verret S
    Vie Med Can Fr; 1973 Jul; 2(7):649-55. PubMed ID: 4760948
    [No Abstract]   [Full Text] [Related]  

  • 33. The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: a comparison with placebo and methylphenidate.
    Hunt RD; Minderaa RB; Cohen DJ
    Psychopharmacol Bull; 1986; 22(1):229-36. PubMed ID: 3523578
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hypermotoric syndrome in childhood].
    Harbauer H
    Dtsch Med Wochenschr; 1980 Mar; 105(11):355-7. PubMed ID: 7363769
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder.
    Handen BL; Breaux AM; Gosling A; Ploof DL; Feldman H
    Pediatrics; 1990 Dec; 86(6):922-30. PubMed ID: 2135682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Attention deficit disorder with hyperactivity (ADHD). Continuing symptom control with medium term methylphenidate treatment].
    Oberpichler-Schwenk H
    Med Monatsschr Pharm; 2006 Nov; 29(11):415-6. PubMed ID: 17131689
    [No Abstract]   [Full Text] [Related]  

  • 37. Teacher response to the methylphenidate (ritalin) versus placebo status of hyperactive boys in the classroom.
    Whalen CK; Henker B; Dotemoto S
    Child Dev; 1981 Sep; 52(3):1005-14. PubMed ID: 7026186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Methylphenidate reaction.
    Sleator EK
    Pediatrics; 1975 Jun; 55(6):895-6. PubMed ID: 1134893
    [No Abstract]   [Full Text] [Related]  

  • 39. Attention-deficit hyperactivity disorder, methylphenidate, and primary encopresis.
    Golubchik P; Weizman A
    Psychosomatics; 2009; 50(2):178. PubMed ID: 19377031
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased urine phenylethylamine after methylphenidate treatment in children with ADHD.
    Kusaga A; Yamashita Y; Koeda T; Hiratani M; Kaneko M; Yamada S; Matsuishi T
    Ann Neurol; 2002 Sep; 52(3):372-4. PubMed ID: 12205654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.